Financials data is unavailable for this security.
Cash flow in AUDView more
In 2024, Chimeric Therapeutics Ltd increased its cash reserves by 29.22%, or 690.35k. Cash Flow from Financing totalled 8.26m or -- of revenues. In addition the company used 7.54m for operations while cash from investing was breakeven.
Cash flow per share | -- |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.0028 |
---|---|
Tangible book value per share | -0.0109 |
More ▼
Balance sheet in AUDView more
Current ratio | 0.3191 |
---|---|
Quick ratio | -- |
Total debt/total equity | 1.10 |
---|---|
Total debt/total capital | 0.5228 |
More ▼